Hualan Biological Engineering
002007.SZ
#2880
Rank
A$6.75 B
Marketcap
$3.69
Share price
1.50%
Change (1 day)
-6.10%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2024 (TTM): A$0.35 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are A$0.69 Billion. In 2023 the company made an earning of A$0.48 Billion, an increase over its 2022 earnings that were of A$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.35 B-26.08%
2023 A$0.48 B39.21%
2022 A$0.34 B-19.12%
2021 A$0.43 B-17.9%
2020 A$0.52 B37.11%
2019 A$0.38 B11.71%
2018 A$0.34 B50.84%
2017 A$0.22 B1.1%
2016 A$0.22 B23.49%
2015 A$0.18 B8.37%
2014 A$0.16 B10.83%
2013 A$0.15 B54.56%
2012 A$98.01 M-17.03%
2011 A$0.11 B-41.34%
2010 A$0.20 B6.15%
2009 A$0.18 B261.3%
2008 A$52.5 M85.75%
2007 A$28.26 M49.27%
2006 A$18.93 M56.98%
2005 A$12.06 M34.28%
2004 A$8.98 M